Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China · Delayed Price · Currency is CNY 10.92
+0.57 (5.51%)
At close: Jan 6, 2026
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 24.35 billion as of January 6, 2026. Its market cap has decreased by -17.54% in one year.
Market Cap
24.35B
Enterprise Value
24.86B
Revenue
4.74B
Ranking
n/a
PE Ratio
26.14
Stock Price
10.92
Market Cap Chart
Since December 27, 2022, SHE:301301's market cap has increased from 22.34B to 24.35B, an increase of 9.01%. That is a compound annual growth rate of 2.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 24.35B | 7.69% |
| Dec 31, 2025 | 22.61B | -14.39% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
| Dec 27, 2022 | 22.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 418.98B |
| WuXi AppTec | 283.87B |
| Shenzhen Mindray Bio-Medical Electronics | 241.39B |
| Sichuan Biokin Pharmaceutical | 133.70B |
| Shanghai United Imaging Healthcare | 108.89B |
| Aier Eye Hospital Group | 103.93B |
| Zhangzhou Pientzehuang Pharmaceutical., | 102.74B |
| Yunnan Baiyao Group Co.,Ltd | 102.40B |